{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:23:34Z","timestamp":1792221814938,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.coph.2008.11.001","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T13:54:19Z","timestamp":1229522059000},"page":"90-95","source":"Crossref","is-referenced-by-count":20,"title":["Thrombomodulation via CLEC-2 targeting"],"prefix":"10.1016","volume":"9","author":[{"given":"Chris A","family":"O\u2019Callaghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2008.11.001_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/01.RES.0000264509.36234.51","article-title":"Clinical aspects of platelet inhibitors and thrombus formation","volume":"100","author":"Meadows","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2008.11.001_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ahj.2007.12.014","volume":"155","author":"Casterella","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.coph.2008.11.001_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.it.2004.07.003","article-title":"Platelets: signaling cells in the immune continuum","volume":"25","author":"Weyrich","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coph.2008.11.001_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/infdis\/166.1.65","article-title":"Characterization of Staphylococcus aureus\u2013platelet binding by quantitative flow cytometric analysis","volume":"166","author":"Yeaman","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2008.11.001_bib5","first-page":"716","article-title":"Role of neutrophils in the deposition of platelets during acute inflammation","volume":"49","author":"Issekutz","year":"1983","journal-title":"Lab Invest"},{"key":"10.1016\/j.coph.2008.11.001_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","article-title":"Platelets as immune cells: bridging inflammation and cardiovascular disease","volume":"100","author":"von Hundelshausen","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2008.11.001_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1521-4141(200002)30:2<697::AID-IMMU697>3.0.CO;2-M","article-title":"Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells","volume":"30","author":"Colonna","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coph.2008.11.001_bib8","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/1521-4141(200112)31:12<3493::AID-IMMU3493>3.0.CO;2-9","article-title":"A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex","volume":"31","author":"Sobanov","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coph.2008.11.001_bib9_1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2005-05-1994","article-title":"A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2","volume":"107","author":"Suzuki-Inoue","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.coph.2008.11.001_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1006\/bbrc.1998.8516","article-title":"Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib","volume":"245","author":"Shin","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2008.11.001_bib11","doi-asserted-by":"crossref","first-page":"20882","DOI":"10.1074\/jbc.M101585200","volume":"276","author":"Navdaev","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.11.001_bib12","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1074\/jbc.M006191200","article-title":"Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia\/IIa (GPIa\/IIa, Integrin alpha 2beta 1). Involvement of GPIa\/IIa-associated src and protein tyrosine phosphorylation","volume":"276","author":"Suzuki-Inoue","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.11.001_bib13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1006\/bbrc.2001.5228","article-title":"Aggretin, a C-type lectin protein, induces platelet aggregation via integrin alpha(2)beta(1) and GPIb in a phosphatidylinositol 3-kinase independent pathway","volume":"285","author":"Chung","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2008.11.001_bib14","doi-asserted-by":"crossref","first-page":"25121","DOI":"10.1074\/jbc.M103892200","article-title":"Rhodocytin (aggretin) activates platelets lacking alpha(2)beta(1) integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibalpha","volume":"276","author":"Bergmeier","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.11.001_bib15_1","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1110\/ps.035568.108","article-title":"Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2","volume":"17","author":"Watson","year":"2008","journal-title":"Protein Sci"},{"key":"10.1016\/j.coph.2008.11.001_bib16","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1128\/JVI.00136-06","article-title":"DC-SIGN and CLEC-2 Mediate Human Immunodeficiency virus type 1 capture by platelets","volume":"80","author":"Chaipan","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coph.2008.11.001_bib17_1","doi-asserted-by":"crossref","first-page":"12397","DOI":"10.1074\/jbc.M609558200","article-title":"The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade","volume":"282","author":"Fuller","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.11.001_bib18","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1538-7836.2008.03166.x","article-title":"Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2","volume":"6","author":"Hughes","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coph.2008.11.001_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI5317","article-title":"Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice","volume":"103","author":"Clements","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2008.11.001_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/09537100600881396","article-title":"Minimal regulation of platelet activity by PECAM-1","volume":"18","author":"Dhanjal","year":"2007","journal-title":"Platelets"},{"key":"10.1016\/j.coph.2008.11.001_bib21_1","doi-asserted-by":"crossref","first-page":"35419","DOI":"10.1074\/jbc.M806895200","article-title":"G6b-B inhibits constitutive and agonist-induced signalling by GPVI and CLEC-2","volume":"283","author":"Mori","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.11.001_bib22_1","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1074\/jbc.M610383200","article-title":"The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2","volume":"282","author":"Watson","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.11.001_bib23","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1107\/S1744309105037991","article-title":"Crystallization and X-ray diffraction analysis of human CLEC-2","volume":"61","author":"Watson","year":"2005","journal-title":"Acta Crystallograph Sect F Struct Biol Cryst Commun"},{"key":"10.1016\/j.coph.2008.11.001_bib24","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1021\/bi800528t","article-title":"The crystal structure of the platelet activator aggretin reveals a novel (alphabeta)2 dimeric structure","volume":"47","author":"Hooley","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.coph.2008.11.001_bib25_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/BJ20071216","article-title":"Renal cells activate the platelet receptor CLEC-2 through podoplanin","volume":"411","author":"Christou","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.coph.2008.11.001_bib26_1","doi-asserted-by":"crossref","first-page":"25993","DOI":"10.1074\/jbc.M702327200","article-title":"Involvement of the snake toxin receptor CLEC-2 in podoplanin-mediated platelet activation by cancer cells","volume":"282","author":"Suzuki-Inoue","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2008.11.001_bib27","first-page":"6657","article-title":"Expression of a Mr 41,000 glycoprotein associated with thrombin-independent platelet aggregation in high metastatic variants of murine B16 melanoma","volume":"50","author":"Watanabe","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.coph.2008.11.001_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.febslet.2006.12.044","article-title":"Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor","volume":"581","author":"Kaneko","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.coph.2008.11.001_bib29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1349-7006.2007.00634.x","article-title":"Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2","volume":"99","author":"Kato","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.coph.2008.11.001_bib30","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1093\/emboj\/cdg342","article-title":"T1alpha\/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema","volume":"22","author":"Schacht","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.coph.2008.11.001_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6603518","article-title":"The potential role of podoplanin in tumour invasion","volume":"96","author":"Wicki","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.coph.2008.11.001_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccr.2006.03.010","article-title":"Tumor invasion in the absence of epithelial\u2013mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton","volume":"9","author":"Wicki","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.coph.2008.11.001_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/hyb.2008.0017","article-title":"Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2","volume":"27","author":"Ogasawara","year":"2008","journal-title":"Hybridoma (Larchmt)"},{"key":"10.1016\/j.coph.2008.11.001_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.1998.tb01238.x","article-title":"The Syk family of protein tyrosine kinases in T-cell activation and development","volume":"165","author":"Chu","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coph.2008.11.001_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.thromres.2004.06.046","article-title":"Platelet glycoprotein VI: its structure and function","volume":"114","author":"Moroi","year":"2004","journal-title":"Thromb Res"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489208001860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489208001860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T05:13:19Z","timestamp":1709788399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489208001860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1471489208001860"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2008.11.001","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}